Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
10XB-101 in adults with submental fat
NCT05154955Phase 2Completed
- Sponsor
- 10xBio
- Start
- Oct 2021
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of 10XB101 in submental fat (4 arms), sponsored by 10xBio. Primary endpoints: Clinician Submental Fat Scale and Patient Submental Fat Scale. Started Oct 2021; status: completed.
02
Drugs
10XB101
03
Conditions
submental fat
Beyond the preview
Go deeper on NCT05154955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05154955.